Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years.
Higher-end products are where the beer category is headed.
The specialty segment, which includes such super-premium brands as Blue Moon, Shock Top and Land Shark, has been strong with volume sales ahead 13% and dollar sales up 15% for the 52 week period ended June 30.
The manufacturer behind the diet-aid supplement Hydroxycut, Iovate Health Sciences International, recently introduced two new formats to its popular weight-loss franchise: Pro Clinical Hydroxycut Sprinkles and Pro Clinical Hydroxycut Gummies.
The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.